Archive: 14/12/2016

Cetuximab + chemoradiation can cure HIV-associated anal cancer

(HealthDay)—Definitive chemoradiation (CRT) can potentially cure HIV-associated squamous cell carcinoma of the anal canal (SCCAC), with the addition of cetuximab resulting in less locoregional failure (LRF), according to ...

Dec 14, 2016

0

0

Addiction consultation valuable for liver transplant patients

(HealthDay)—Liver transplantation (LT) patients should undergo addiction consultation to accurately detect alcohol consumption, according to a study published online Dec. 9 in Alcoholism: Clinical & Experimental Research.

Dec 14, 2016

0

0

Data-driven algorithm yields notable improvements in HbA1c

(HealthDay)—A data-driven algorithm for personalized diabetes care can yield substantial improvements in hemoglobin A1c (HbA1c), according to a study published online Dec. 5 in Diabetes Care.

Dec 14, 2016

0

0

Children's oral health disparities persist despite equal dental care access

Oral health of children who receive dental care through Medicaid lags behind their privately insured peers, even though the children receive the same amount of dental care, according to a study from the Columbia University ...

Dec 14, 2016

Outcomes-based pricing suggested for new, costly drugs

(HealthDay)—Outcomes-based pricing for novel and expensive biopharmaceuticals is supported in an Ideas and Opinions piece published online Dec. 13 in the Annals of Internal Medicine.

Dec 14, 2016

0

0

Type of treatment impacts recurrence in laryngeal SCC

(HealthDay)—For patients with laryngeal squamous cell carcinoma (SCC), factors predictive of recurrence include neck metastasis at presentation and nonsurgical treatment, according to a study published online Nov. 30 in ...

Dec 14, 2016

0

0

Sliding scale insulin order sheet cuts medication errors

(HealthDay)—A standardized sliding scale insulin (SSI) order sheet can reduce the incidence of SSI-related medication errors, according to a study published online Dec. 7 in the Journal of Evaluation in Clinical Practice.

Dec 14, 2016

0

0

Knee cartilage product approved to repair defects

(HealthDay)—Maci (autologous cultured chondrocytes) has been approved by the U.S. Food and Drug Administration to repair defective cartilage of the knee.

Dec 14, 2016